The Effect of Growth Hormone in Very Young Girls With Turner Syndrome

Status Completed

Clinical Trial Summary

This study investigated the effect of growth hormone on the growth of infants and toddlers with Turner syndrome during 2 years of treatment with growth hormone. This was compared with the growth of infants and toddlers with Turner syndrome who did not receive any growth hormone treatment. The overall aim was to prevent the growth failure usually seen during this period. The study also looked at middle ear disease, hearing problems, and cognitive and behavioral development.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00406926
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	August 1999
Completion date	August 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01734486` - Growth Response in Girls With Turner Syndrome	Phase 4
Completed	`NCT01678261` - X-chromosome Inactivation, Epigenetics and the Transcriptome	N/A
Completed	`NCT01419249` - First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study	Phase 4
Completed	`NCT01518036` - Use of Somatropin in Turner Syndrome	Phase 3
Recruiting	`NCT04948658` - Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Completed	`NCT01563926` - Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	Phase 3
Completed	`NCT02787486` - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed	`NCT00877942` - Sex Differences in Early Brain Development; Brain Development in Turner Syndrome	N/A
Completed	`NCT00825617` - Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy	N/A
Recruiting	`NCT04463316` - GROWing Up With Rare GENEtic Syndromes
Enrolling by invitation	`NCT03836300` - Parent and Infant Inter(X)Action Intervention (PIXI)	N/A
Completed	`NCT01245374` - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents	Phase 4
Completed	`NCT01322165` - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions	N/A
Terminated	`NCT00419107` - Beta Cell Function in Women With Turner Syndrome	N/A
Active, not recruiting	`NCT00625001` - Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome	N/A
Completed	`NCT00029159` - The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome	Phase 3
Completed	`NCT01518062` - Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome	Phase 4
Completed	`NCT00471731` - Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure	N/A
Completed	`NCT00256126` - Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®	Phase 4
Completed	`NCT03181230` - Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome